BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31330140)

  • 21. Arsenic methylation metabolism and liver injury of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
    Wang H; Xi S; Liu Z; Yang Y; Zheng Q; Wang F; Xu Y; Wang Y; Zheng Y; Sun G
    Environ Toxicol; 2013 May; 28(5):267-75. PubMed ID: 23589229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arsenic Trioxide Therapy During Pregnancy: ATO and Its Metabolites in Maternal Blood and Amniotic Fluid of Acute Promyelocytic Leukemia Patients.
    Guo M; Lv J; Chen X; Wu M; Zhao Q; Hai X
    Front Oncol; 2022; 12():887026. PubMed ID: 35646703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variation in arsenic (+3 oxidation state) methyltransferase (AS3MT), arsenic metabolism and risk of basal cell carcinoma in a European population.
    Engström KS; Vahter M; Fletcher T; Leonardi G; Goessler W; Gurzau E; Koppova K; Rudnai P; Kumar R; Broberg K
    Environ Mol Mutagen; 2015 Jan; 56(1):60-9. PubMed ID: 25156000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacokinetics and safety profile of single agent arsenic trioxide by continuous slow-rate infusion in patients with newly diagnosed acute promyelocytic leukemia.
    Gao C; Hu S; Guo M; Hai X; Zhou J
    Cancer Chemother Pharmacol; 2018 Aug; 82(2):229-236. PubMed ID: 29845392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary arsenic metabolism in a Western Chinese population exposed to high-dose inorganic arsenic in drinking water: influence of ethnicity and genetic polymorphisms.
    Fu S; Wu J; Li Y; Liu Y; Gao Y; Yao F; Qiu C; Song L; Wu Y; Liao Y; Sun D
    Toxicol Appl Pharmacol; 2014 Jan; 274(1):117-23. PubMed ID: 24239724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Speciation analysis of arsenic in urine samples from APL patients treated with single agent As
    Guo M; Li J; Fan S; Liu W; Wang B; Gao C; Zhou J; Hai X
    J Pharm Biomed Anal; 2019 Jul; 171():212-217. PubMed ID: 31009876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of arsenic-induced cardiovascular disease susceptibility with genetic polymorphisms.
    Al-Forkan M; Wali FB; Khaleda L; Alam MJ; Chowdhury RH; Datta A; Rahman MZ; Hosain N; Maruf MF; Chowdhury MAQ; Hasan NKMM; Shawon II; Raqib R
    Sci Rep; 2021 Mar; 11(1):6263. PubMed ID: 33737636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biotransformation of arsenic trioxide by AS3MT favors eradication of acute promyelocytic leukemia: revealing the hidden facts.
    Maimaitiyiming Y; Zhu HH; Yang C; Naranmandura H
    Drug Metab Rev; 2020 Aug; 52(3):425-437. PubMed ID: 32677488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenic metabolites; selenium; and AS3MT, MTHFR, AQP4, AQP9, SELENOP, INMT, and MT2A polymorphisms in Croatian-Slovenian population from PHIME-CROME study.
    Stajnko A; Šlejkovec Z; Mazej D; France-Štiglic A; Briški AS; Prpić I; Špirić Z; Horvat M; Falnoga I
    Environ Res; 2019 Mar; 170():301-319. PubMed ID: 30612060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics and clinical influence factors of arsenic species in plasma and their role of arsenic species as predictors for clinical efficacy in acute promyelocytic leukemia (APL) patients treated with arsenic trioxide.
    Guo M; Zhou J; Fan S; Li L; Chen H; Lin L; Zhao Q; Wang X; Liu W; Wu Z; Hai X
    Expert Rev Clin Pharmacol; 2021 Apr; 14(4):503-512. PubMed ID: 33678104
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of arsenic (+3 oxidation state) methyltransferase in arsenic mediated APL treatment: an in vitro investigation.
    Maimaitiyiming Y; Wang C; Xu S; Islam K; Chen YJ; Yang C; Wang QQ; Naranmandura H
    Metallomics; 2018 Jun; 10(6):828-837. PubMed ID: 29774349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation of polymorphism of arsenic metabolism genes to arsenic methylation capacity and developmental delay in preschool children in Taiwan.
    Hsieh RL; Su CT; Shiue HS; Chen WJ; Huang SR; Lin YC; Lin MI; Mu SC; Chen RJ; Hsueh YM
    Toxicol Appl Pharmacol; 2017 Apr; 321():37-47. PubMed ID: 28235556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of gamma-glutamyltransferase in acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
    Sui M; Wei H; Zhang Q; Xiu R; Shen X; Zhang Z; Zhou J
    Hematology; 2021 Dec; 26(1):58-64. PubMed ID: 33402059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of arsenic methylation capacity and polymorphisms of arsenic methylation genes between bladder cancer and upper tract urothelial carcinoma.
    Huang CY; Lin YC; Shiue HS; Chen WJ; Su CT; Pu YS; Ao PL; Hsueh YM
    Toxicol Lett; 2018 Oct; 295():64-73. PubMed ID: 29859237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations between arsenic (+3 oxidation state) methyltransferase (AS3MT) and N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) polymorphisms, arsenic metabolism, and cancer risk in a chilean population.
    de la Rosa R; Steinmaus C; Akers NK; Conde L; Ferreccio C; Kalman D; Zhang KR; Skibola CF; Smith AH; Zhang L; Smith MT
    Environ Mol Mutagen; 2017 Jul; 58(6):411-422. PubMed ID: 28640505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene-environment interaction and maternal arsenic methylation efficiency during pregnancy.
    Gao S; Mostofa MG; Quamruzzaman Q; Rahman M; Rahman M; Su L; Hsueh YM; Weisskopf M; Coull B; Christiani DC
    Environ Int; 2019 Apr; 125():43-50. PubMed ID: 30703610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-6-adenine-specific DNA methyltransferase 1 (N6AMT1) polymorphisms and arsenic methylation in Andean women.
    Harari F; Engström K; Concha G; Colque G; Vahter M; Broberg K
    Environ Health Perspect; 2013 Jul; 121(7):797-803. PubMed ID: 23665909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The level of exposure affects the arsenic urinary methylation profile of a population of children.
    Olmos V; Astolfo MA; Sassone AH; Villaamil Lepori EC
    J Hazard Mater; 2021 Aug; 415():125623. PubMed ID: 33740719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradation.
    Wang QQ; Zhou XY; Zhang YF; Bu N; Zhou J; Cao FL; Naranmandura H
    Oncotarget; 2015 Sep; 6(28):25646-59. PubMed ID: 26213848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex differences in the reduction of arsenic methylation capacity as a function of urinary total and inorganic arsenic in Mexican children.
    Torres-Sánchez L; López-Carrillo L; Rosado JL; Rodriguez VM; Vera-Aguilar E; Kordas K; García-Vargas GG; Cebrian ME
    Environ Res; 2016 Nov; 151():38-43. PubMed ID: 27450997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.